https://orcid.org/0000-0001-8144-0558
Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Basak Simitcioglu, Isik Didem Karagoz, Sibel Ilbasmis-Tamer & Ugur Tamer. (2022) Effect of different molecular weight and terminal group PLGA on docetaxel nanoparticles: characterization and cytotoxic activity of castration-resistant prostate cancer cells. Pharmaceutical Development and Technology 27:7, pages 794-804.
Read now
Read now
Sajad Fakhri, Sadaf Abdian, Seyede Nazanin Zarneshan, Seyed Zachariah Moradi, Mohammad Hosein Farzaei & Mohammad Abdollahi. (2022) Nanoparticles in Combating Neuronal Dysregulated Signaling Pathways: Recent Approaches to the Nanoformulations of Phytochemicals and Synthetic Drugs Against Neurodegenerative Diseases. International Journal of Nanomedicine 17, pages 299-331.
Read now
Read now
Saima Zameer, Javed Ali, Divya Vohora, Abul Kalam Najmi & Mohd Akhtar. (2021) Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer’s disease in intracerebroventricular streptozotocin model for brain delivery. Journal of Drug Targeting 29:2, pages 199-216.
Read now
Read now
Silvia Cerri & Fabio Blandini. (2020) An update on the use of non-ergot dopamine agonists for the treatment of Parkinson’s disease. Expert Opinion on Pharmacotherapy 21:18, pages 2279-2291.
Read now
Read now
Sara Salatin, Mitra Alami-Milani, Rosita Daneshgar & Mitra Jelvehgari. (2018) Box–Behnken experimental design for preparation and optimization of the intranasal gels of selegiline hydrochloride. Drug Development and Industrial Pharmacy 44:10, pages 1613-1621.
Read now
Read now
Articles from other publishers (42)
Xiaomei Yao, Yichao Guan, Jianli Wang & Dong Wang. (2024) Cerium oxide nanoparticles modulating the Parkinson's disease conditions: From the alpha synuclein structural point of view and antioxidant properties of cerium oxide nanoparticles. Heliyon 10:1, pages e21789.
Crossref
Crossref
Rajeswara Babu MythriM.R. Aishwarya. (2023) BIOPOLYMERS AS PROMISING VEHICLES FOR DRUG DELIVERY TO THE BRAIN. Drug Metabolism Reviews, pages 1-40.
Crossref
Crossref
Suven Das & Arpita Dutta. (2023) Rhodium-catalyzed annulation for the construction of indole core: An update. Tetrahedron 146, pages 133633.
Crossref
Crossref
Krunal Detholia, Amrutha Mohandas, Umang Varia, Mukesh Jadeja & Hitesh Katariya. (2023) Development and optimization of Ropinirole loaded self-nanoemulsifying tablets. Future Journal of Pharmaceutical Sciences 9:1.
Crossref
Crossref
Yue Lu, Dongfang Cheng, Baohua Niu, Xiuzhi Wang, Xiaxia Wu & Aiping Wang. (2023) Properties of Poly (Lactic-co-Glycolic Acid) and Progress of Poly (Lactic-co-Glycolic Acid)-Based Biodegradable Materials in Biomedical Research. Pharmaceuticals 16:3, pages 454.
Crossref
Crossref
Andrea Vaquero-Rodríguez, Jone Razquin, Maider Zubelzu, Raphaelle Bidgood, Harkaitz Bengoetxea, Cristina Miguelez, Teresa Morera-Herreras, Jose Angel Ruiz-Ortega, José Vicente Lafuente & Naiara Ortuzar. 2023. Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-Morbidity Factors Part B. Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-Morbidity Factors Part B
103
143
.
Naumih M. Noah & Peter M. Ndangili. 2023. Polymeric Nanosystems. Polymeric Nanosystems
723
759
.
Nicola Paccione, Mahdieh Rahmani, Emilia Barcia & Sofía Negro. (2022) Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems. Pharmaceutics 15:1, pages 13.
Crossref
Crossref
Obaid Afzal, Abdulmalik S. A. Altamimi, Muhammad Shahid Nadeem, Sami I. Alzarea, Waleed Hassan Almalki, Aqsa Tariq, Bismillah Mubeen, Bibi Nazia Murtaza, Saima Iftikhar, Naeem Riaz & Imran Kazmi. (2022) Nanoparticles in Drug Delivery: From History to Therapeutic Applications. Nanomaterials 12:24, pages 4494.
Crossref
Crossref
Ahmed Hafez Mousa & Salwa Agha Mohammad. (2022) Potential role of chitosan, PLGA and iron oxide nanoparticles in Parkinson’s disease therapy. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 58:1.
Crossref
Crossref
Guowang Cheng, Yujing Liu, Rui Ma, Guopan Cheng, Yucheng Guan, Xiaojia Chen, Zhenfeng Wu & Tongkai Chen. (2022) Anti-Parkinsonian Therapy: Strategies for Crossing the Blood–Brain Barrier and Nano-Biological Effects of Nanomaterials. Nano-Micro Letters 14:1.
Crossref
Crossref
Marcelo Garrido dos Santos, João Pedro Prestes & Patricia Pranke. (2022) Nanopolymers: Powerful Tools in Neuroprotection and Neuroregeneration. Current Nanoscience 18:6, pages 668-674.
Crossref
Crossref
Mario Alonso-González, Ana Fernández-Carballido, Prissila Quispe-Chauca, Irene Lozza, Cristina Martín-Sabroso & Ana Isabel Fraguas-Sánchez. (2022) DoE-based development of celecoxib loaded PLGA nanoparticles: In ovo assessment of its antiangiogenic effect. European Journal of Pharmaceutics and Biopharmaceutics 180, pages 149-160.
Crossref
Crossref
Miguel Pinto, Vera Silva, Sandra Barreiro, Renata Silva, Fernando Remião, Fernanda Borges & Carlos Fernandes. (2022) Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform. Ageing Research Reviews 79, pages 101658.
Crossref
Crossref
Abdullahi Tunde Aborode, Manas Pustake, Wireko Andrew Awuah, Mariam Alwerdani, Parth Shah, Rohan Yarlagadda, Shahzaib Ahmad, Inês F. Silva Correia, Ayush Chandra, Esther Patience Nansubuga, Toufik Abdul-Rahman, Aashna Mehta, Omar Ali, Shekinah Obinna Amaka, Yves Miel H. Zuñiga, Anastasiia D. Shkodina, Oko Christian Inya, Bairong Shen & Athanasios Alexiou. (2022) Targeting Oxidative Stress Mechanisms to Treat Alzheimer’s and Parkinson’s Disease: A Critical Review. Oxidative Medicine and Cellular Longevity 2022, pages 1-9.
Crossref
Crossref
Wael M. Darwish, Noha A. Bayoumi & Nahed H. Ebeid. (2022) Biocompatible mucoadhesive nanoparticles for brain targeting of ropinirole hydrochloride: Formulations, radiolabeling and biodistribution. Biopolymers 113:6.
Crossref
Crossref
Yaquelyn Casanova, Sofía Negro, Karla Slowing, Luis García-García, Ana Fernández-Carballido, Mahdieh Rahmani & Emilia Barcia. (2022) Micro- and Nano-Systems Developed for Tolcapone in Parkinson’s Disease. Pharmaceutics 14:5, pages 1080.
Crossref
Crossref
Yaquelyn Casanova, Sofia Negro & Emilia Barcia. (2022) Application of neurotoxin- and pesticide-induced animal models of Parkinson’s disease in the evaluation of new drug delivery systems. Acta Pharmaceutica 72:1, pages 35-58.
Crossref
Crossref
Rupinder Kaur Sodhi, Jitender Madan, M. Arockia Babu & Yuvraj Singh. 2022. Multifunctional Nanocarriers. Multifunctional Nanocarriers
419
439
.
Fong LaiGuan Zoey, Mathangi Palanivel, Parasuraman Padmanabhan & Balázs Gulyás. (2021) Parkinson’s Disease: A Nanotheranostic Approach Targeting Alpha-Synuclein Aggregation. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Uma Maheswari Krishnan. (2021) Biomaterials in the treatment of Parkinson's disease. Neurochemistry International 145, pages 105003.
Crossref
Crossref
Sara Silva, António Almeida & Nuno Vale. (2021) Importance of Nanoparticles for the Delivery of Antiparkinsonian Drugs. Pharmaceutics 13:4, pages 508.
Crossref
Crossref
Jiali Zhu & Min Chen. (2021) The effect and safety of ropinirole in the treatment of Parkinson disease. Medicine 100:46, pages e27653.
Crossref
Crossref
Suresh Thangudu, Fong-Yu Cheng & Chia-Hao Su. (2020) Advancements in the Blood–Brain Barrier Penetrating Nanoplatforms for Brain Related Disease Diagnostics and Therapeutic Applications. Polymers 12:12, pages 3055.
Crossref
Crossref
Soumajit Mukherjee, Zuzana Bytesnikova, Amir M. Ashrafi, Vojtech Adam & Lukas Richtera. (2020) Graphene Oxide as a Nanocarrier for Biochemical Molecules: Current Understanding and Trends. Processes 8:12, pages 1636.
Crossref
Crossref
Aikaterini-Theodora Chatzitaki, Sandra Jesus, Christina Karavasili, Dimitrios Andreadis, Dimitrios G. Fatouros & Olga Borges. (2020) Chitosan-coated PLGA nanoparticles for the nasal delivery of ropinirole hydrochloride: In vitro and ex vivo evaluation of efficacy and safety. International Journal of Pharmaceutics 589, pages 119776.
Crossref
Crossref
Yung-Chih Kuo & Rajendiran Rajesh. (2020) Particulate systems for improving therapeutic efficacy of pharmaceuticals against central nervous system-related diseases. Journal of the Taiwan Institute of Chemical Engineers 114, pages 12-23.
Crossref
Crossref
Tao Ming Sim, Dinesh Tarini, S. Thameem Dheen, Boon Huat Bay & Dinesh Kumar Srinivasan. (2020) Nanoparticle-Based Technology Approaches to the Management of Neurological Disorders. International Journal of Molecular Sciences 21:17, pages 6070.
Crossref
Crossref
Sheril Ann Mathew, P. Praveena, S. Dhanavel, R. Manikandan, S. Senthilkumar & A. Stephen. (2020) Luminescent chitosan/carbon dots as an effective nano-drug carrier for neurodegenerative diseases. RSC Advances 10:41, pages 24386-24396.
Crossref
Crossref
Kuldeep Rajpoot. (2020) Nanotechnology-based Targeting of Neurodegenerative Disorders: A Promising Tool for Efficient Delivery of Neuromedicines. Current Drug Targets 21:8, pages 819-836.
Crossref
Crossref
Celina Cahalane, Jason Bonezzi, John Shelestak, Robert Clements, Aliaksei Boika, Yang H. Yun & Leah P. Shriver. (2020) Targeted Delivery of Anti-inflammatory and Imaging Agents to Microglial Cells with Polymeric Nanoparticles. Molecular Pharmaceutics 17:6, pages 1816-1826.
Crossref
Crossref
Jyoti Ahlawat, Rabin Neupane, Eva Deemer, Sreeprasad T. Sreenivasan & Mahesh Narayan. (2020) Chitosan–Ellagic Acid Nanohybrid for Mitigating Rotenone-induced Oxidative Stress. ACS Applied Materials & Interfaces 12:16, pages 18964-18977.
Crossref
Crossref
G.Y. Wang, S.L. Rayner, R. Chung, B.Y. Shi & X.J. Liang. (2020) Advances in nanotechnology-based strategies for the treatments of amyotrophic lateral sclerosis. Materials Today Bio 6, pages 100055.
Crossref
Crossref
Shahryar Shakeri, Milad Ashrafizadeh, Ali Zarrabi, Rasoul Roghanian, Elham Ghasemipour Afshar, Abbas Pardakhty, Reza Mohammadinejad, Anuj Kumar & Vijay Kumar Thakur. (2020) Multifunctional Polymeric Nanoplatforms for Brain Diseases Diagnosis, Therapy and Theranostics. Biomedicines 8:1, pages 13.
Crossref
Crossref
Priya Shrivastava, Sonal Vyas, Rajeev Sharma, Nishi Mody, Laxmikant Gautam, Anamika Jain, Nikhar Vishwakarma & Suresh P. Vyas. 2020. Nanoengineered Biomaterials for Advanced Drug Delivery. Nanoengineered Biomaterials for Advanced Drug Delivery
473
498
.
Xiangjun Peng, Yong Zeng, Hai Liu, Xianyun Xu, Minhong Zhang & Qian Liu. (2019) From indoles to 3,3′-biindolin-2-ones: copper-catalyzed oxidative homocoupling of indoles. New Journal of Chemistry 43:38, pages 15153-15160.
Crossref
Crossref
Yutian Ma, Christina Cortez-Jugo, Jianhua Li, Zhixing Lin, Rachael T. Richardson, Yiyuan Han, Jiajing Zhou, Mattias Björnmalm, Orlagh M. Feeney, Qi-Zhi Zhong, Christopher J. H. Porter, Andrew K. Wise & Frank Caruso. (2019) Engineering Biocoatings To Prolong Drug Release from Supraparticles. Biomacromolecules 20:9, pages 3425-3434.
Crossref
Crossref
Kevin Liaw, Zhi Zhang & Sujatha Kannan. (2019) Neuronanotechnology for brain regeneration. Advanced Drug Delivery Reviews 148, pages 3-18.
Crossref
Crossref
Eleonora Calzoni, Alessio Cesaretti, Alice Polchi, Alessandro Di Michele, Brunella Tancini & Carla Emiliani. (2019) Biocompatible Polymer Nanoparticles for Drug Delivery Applications in Cancer and Neurodegenerative Disorder Therapies. Journal of Functional Biomaterials 10:1, pages 4.
Crossref
Crossref
Diana Sousa, Débora Ferreira, Joana L. Rodrigues & Lígia R. Rodrigues. 2019. Applications of Targeted Nano Drugs and Delivery Systems. Applications of Targeted Nano Drugs and Delivery Systems
357
409
.
Mahendra Rai, Alka Yadav, Avinsh P. Ingle, Anatoly Reshetilov, María José Blanco-Prieto & Chistiane M. Feitosa. 2019. Nanobiotechnology in Neurodegenerative Diseases. Nanobiotechnology in Neurodegenerative Diseases
1
17
.
Somasree Ray, Pratyusha Sinha, Bibek Laha, Sabyasachi Maiti, Uttam Kumar Bhattacharyya & Amit Kumar Nayak. (2018) Polysorbate 80 coated crosslinked chitosan nanoparticles of ropinirole hydrochloride for brain targeting. Journal of Drug Delivery Science and Technology 48, pages 21-29.
Crossref
Crossref